CBUS Cibus, Inc.
Agricultural Chemicals · Nasdaq · SEC CIK 1705843 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY19.5%
TTM net income YoY18.8%
TTM EPS YoY46.1%
Revenue 3-yr CAGR81.7%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-1,326.7%
Net margin-2,131.4%
FCF margin-966.0%
EBITDA margin-1,243.0%
Returns
ROE-431.9%
ROA-30.6%
ROIC (approx.)-826.6%
Asset turnover0.01x
Leverage & solvency
Liabilities / assets101.9%
Debt / equity—
Current ratio0.95x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.45x
Accruals ratio-16.8%
Payout ratio—
Capex / revenue3.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.64M | $4.26M | $1.82M | $157,000 | $25.99M |
| Cost of revenue | — | — | — | $0 | $28.56M |
| Gross profit | — | — | — | $157,000 | -$2.57M |
| R&D expense | $44.20M | $50.43M | $42.37M | $11.55M | $11.34M |
| SG&A expense | $26.91M | $30.80M | $28.91M | $10.97M | — |
| Operating income | -$97.53M | -$258.40M | -$318.88M | -$22.37M | -$29.33M |
| Interest expense | — | — | — | $75,000 | $1.43M |
| Pretax income | -$132.17M | -$282.68M | -$337.64M | -$16.89M | -$29.20M |
| Income tax | $29,000 | $29,000 | -$4,000 | $0 | $0 |
| Net income | -$127.08M | -$251.39M | -$267.63M | -$16.89M | -$29.20M |
| EBITDA | -$91.61M | -$251.54M | -$314.19M | -$20.84M | -$26.99M |
| EPS (basic) | -2.78 | -10.83 | -25.95 | -18.36 | -0.78 |
| EPS (diluted) | -2.78 | -10.83 | -25.95 | -18.36 | -0.78 |
| Weighted avg. shares (diluted) | 45.76M | 23.22M | 10.31M | 919,959 | 37.48M |
| Balance sheet | |||||
| Cash & equivalents | $9.92M | $14.43M | $32.70M | $3.53M | $14.42M |
| Short-term investments | — | — | — | $0 | $0 |
| Receivables | $503,000 | $1.04M | $530,000 | $0 | $0 |
| Inventory | — | — | — | — | $0 |
| Current assets | $12.07M | $16.95M | $35.22M | $4.13M | $15.18M |
| PP&E, net | $6.30M | $11.44M | $15.78M | $4.52M | $21.73M |
| Goodwill | $232.52M | $253.47M | $434.90M | $0 | — |
| Intangibles | $31.68M | $33.58M | $35.41M | $158,000 | — |
| Total assets | $305.05M | $350.07M | $544.41M | $22.42M | $37.19M |
| Current liabilities | $16.86M | $19.88M | $21.32M | $1.66M | $4.85M |
| Short-term debt | $435,000 | $436,000 | $833,000 | $0 | — |
| Long-term debt | $93,000 | $226,000 | $536,000 | $0 | $0 |
| Total debt | $528,000 | $662,000 | $1.37M | $0 | $0 |
| Total liabilities | $283.22M | $252.24M | $206.12M | $15.19M | $23.06M |
| Shareholders' equity | $21.83M | $92.16M | $293.47M | $7.23M | $14.13M |
| Net debt | -$9.39M | -$13.77M | -$31.33M | -$3.53M | -$14.42M |
| Shares outstanding | — | 29.66M | 23.71M | 4.88M | 38.77M |
| Cash flow statement | |||||
| Operating cash flow | -$50.59M | -$58.04M | -$46.21M | -$19.36M | -$18.81M |
| Capital expenditure | $578,000 | $808,000 | $4.32M | $1.52M | $497,000 |
| Free cash flow | -$51.17M | -$58.85M | -$50.53M | -$20.88M | -$19.31M |
| Investing cash flow | -$578,000 | -$808,000 | $55.06M | -$1.52M | $11.20M |
| Financing cash flow | $46.65M | $40.60M | $20.32M | $9.99M | $3.74M |
| Depreciation & amortization | $5.92M | $6.86M | $4.69M | $1.53M | $2.34M |
| Stock-based compensation | $8.19M | $10.75M | $16.09M | $4.00M | $2.09M |
Free plan shows the latest 5 periods; Pro shows all 11 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.